Director Protopapas Anna sold $5,009 worth of shares (8,637 units at $0.58) and converted options into 21,250 shares, increasing direct ownership by 8% to 168,041 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

MRSN· Mersana Therapeutics Inc.

Health Care

Original source

Director Protopapas Anna sold $5,009 worth of shares (8,637 units at $0.58) and converted options into 21,250 shares, increasing direct ownership by 8% to 168,041 units (SEC Form 4) | Quantisnow